Samil Pharmaceutical Co.,Ltd (KRX:000520)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,340
+150 (1.34%)
At close: Jul 18, 2025, 3:30 PM KST

Samil Pharmaceutical Co.,Ltd Company Description

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea.

It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents.

The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.

Samil Pharmaceutical Co.,Ltd
CountrySouth Korea
Founded1947
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees583
CEOKang Huh

Contact Details

Address:
155 Hyoryeong-Ro
Seoul
South Korea
Phone82 2 520 0300
Websitesamil-pharm.com

Stock Details

Ticker Symbol000520
ExchangeKorea Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
ISIN NumberKR7000520007
SIC Code2834

Key Executives

NamePosition
Kang HuhChief Executive Officer
Boo-Hwan KoPresident